Intermittent fasting during adjuvant chemotherapy may promote differential stress resistance in breast cancer patients.
Enas M OmarGamal A OmranMohamed F MustafaNoha M El-KhodaryPublished in: Journal of the Egyptian National Cancer Institute (2022)
IF throughout chemotherapy was well tolerated and decreased the toxicity of chemotherapy. Additionally, IF-improved metabolic profiles of patients may have a positive impact on the clinical efficacy of chemotherapy.
Keyphrases
- locally advanced
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- squamous cell carcinoma
- oxidative stress
- rectal cancer
- insulin resistance
- blood glucose
- adipose tissue
- blood pressure
- radiation therapy
- high intensity
- patient reported outcomes
- patient reported
- stress induced